iECURE
PrivateLast Round
Series A
Extension
Nov 30, 2022
Total Funding Raised
$115M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
iECURE is a biotechnology company developing genome editing therapies for rare, life-threatening genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iECURE Comparables
Compare iECURE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genespire | 79% | |
| Precision BioSciences | 74% | |
| Vivet Therapeutics | 74% | |
iECURE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 30, 2022 | ||||
| Series A | Sep 9, 2021 |
Key People
Founding team and executive leadership
iECURE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LYFE Capital | Series A Extension |
| OrbiMed | Series A Extension, Series A |
| Versant Ventures | Series A Extension, Series A |
| Novo Holdings | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 53% MoM, reaching 2.8K.
- Oct 2, 2025
Presenting ECUR-506 data at the American Society of Human Genetics Annual Meeting.
iECURE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iECURE's valuation, stock price, and market status.